FULL DETAILS (Read-only)  -> Click Here to Create PDF for Current Dataset of Trial
CTRI Number  CTRI/2012/11/003118 [Registered on: 16/11/2012] Trial Registered Retrospectively
Last Modified On: 09/11/2012
Post Graduate Thesis  Yes 
Type of Trial  Interventional 
Type of Study   Surgical/Anesthesia 
Study Design  Other 
Public Title of Study   to study whether laparoscopic bile duct exploration after failed endoscopy – does it differ from a primary bile duct exploration 
Scientific Title of Study   A Prospective Study To Compare The Outcomes After Primary Laparoscopic Exploration Of Common Bile Duct And Laparoscopic Exploration Following Failed Endoscopic Stone Extraction In Patients With Concomitant Gall Stones And Common Bile Duct Stones 
Trial Acronym   
Secondary IDs if Any  
Secondary ID  Identifier 
NIL  NIL 
 
Details of Principal Investigator or overall Trial Coordinator (multi-center study)  
Name  Virinder Kumar Bansal 
Designation  Additional Professor of Surgery 
Affiliation  All India Institute of Medical Sciences, New Delhi, India 
Address  Room No. 5021, Department of Surgical Disciplines, AIIMS, Ansari Nagar, New Delhi-110029

South
DELHI
110029
India 
Phone  01126593686  
Fax  01126588324  
Email  drvkbansal@gmail.com  
 
Details of Contact Person
Scientific Query
 
Name  Virinder Kumar Bansal 
Designation  Additional Professor of Surgery 
Affiliation  All India Institute of Medical Sciences, New Delhi, India 
Address  Room No. 5021, Department of Surgical Disciplines, AIIMS, Ansari Nagar, New Delhi-110029

South
DELHI
110029
India 
Phone  01126593686  
Fax  01126588324  
Email  drvkbansal@gmail.com  
 
Details of Contact Person
Public Query
 
Name  Karthik Rajan 
Designation  Junior Resident 
Affiliation  All India Institute of Medical Sciences, New Delhi, India 
Address  Department of Surgical Disciplines, AIIMS, Ansari Nagar, New Delhi-110029

South
DELHI
110029
India 
Phone  01126593686  
Fax  01126588324  
Email  karthikrajan.163@gmail.com  
 
Source of Monetary or Material Support  
AIIMS New Delhi 
 
Primary Sponsor  
Name  AIIMS 
Address  Ansari Nagar, New Delhi-29 
Type of Sponsor  Research institution and hospital 
 
Details of Secondary Sponsor  
Name  Address 
NIL  NIL 
 
Countries of Recruitment     India  
Sites of Study  
No of Sites = 1  
Name of Principal Investigator  Name of Site  Site Address  Phone/Fax/Email 
Virinder Kumar Bansal  All India Institute of Medical Sciences, New Delhi, India  Department of Surgical Disciplines, AIIMS, Ansari Nagar, New Delhi-110029
South
DELHI 
01126593686
01126588324
drvkbansal@gmail.com 
 
Details of Ethics Committee  
No of Ethics Committees= 1  
Name of Committee  Approval Status 
Institute Ethics Committee, All India Institute of Medical Sciences  Approved 
 
Regulatory Clearance Status from DCGI  
Status 
Not Applicable 
 
Health Condition / Problems Studied  
Health Type  Condition 
Patients  ASA 1/2 pateints with concomitant CBD stones and gall stones,  
 
Intervention / Comparator Agent  
Type  Name  Details 
Comparator Agent  Group I: Patients with gallstones and common bile duct stones without any prior intervention  patients will undergo a single staged procedure i.e. laparoscopic cholecystectomy with laparoscopic common bile duct exploration and stone clearance 
Comparator Agent  Group II: Patients with gallstones and common bile duct stones with prior attempts at endoscopic stone extraction  patients will undergo a single staged procedure i.e. laparoscopic cholecystectomy with laparoscopic common bile duct exploration and stone clearance 
Intervention  Laparoscopic Common bile duct exploration  Group I: Patients with gallstones and common bile duct stones without any prior intervention Group II: Patients with gallstones and common bile duct stones with prior attempts at endoscopic stone extraction All the patients will undergo a single staged procedure i.e. laparoscopic cholecystectomy with laparoscopic common bile duct exploration and stone clearance  
 
Inclusion Criteria  
Age From  18.00 Year(s)
Age To  80.00 Year(s)
Gender  Both 
Details  1.Patients with both symptomatic gall stones and choledocholithiasis
2.Patients in whom a prior ERCP had failed to extract a CBD stone

Failure of ERCP will be defined as:
1.Unsuitable anatomy such as gastric outlet obstruction, large periampullary diverticulum
2.Failure to cannulate the bile duct
3.Failure to perform adequate sphincterotomy
4.Failure to extract the stone for various reasons such as large stone, impacted stones and/or multiple stones
 
 
ExclusionCriteria 
Details  1.Patients with acute cholecystitis
2.Patients with acute cholangitis
3.Patients with obstructive jaundice with serum bilirubin > 15mg/dl
4.Patients with post ERCP pancreatitis
5.Patients who do not give consent for participate in the study
6.Patients with previous hepatobiliary surgery
7.Patients with morbid obesity
8.Patients with uncorrectable coagulopathy
9.Patients unfit for GA
10.Patients with significant comorbid conditions
 
 
Method of Generating Random Sequence   Not Applicable 
Method of Concealment   Not Applicable 
Blinding/Masking   Not Applicable 
Primary Outcome  
Outcome  TimePoints 
• To assess the success and complications of laparoscopic CBD exploration for choledocholithiasis after unsuccessful endoscopic stone extraction to extract common bile duct stones
• To compare the success, ease of surgery and complications between primary laparoscopic CBD exploration and laparoscopic CBD exploration following unsuccessful endoscopic stone extraction
 
All patients will be followed postoperatively at 1 week, 3 months, 6 months and at one year or till the time they are stone free. Postoperative course of the patients will be noted 
 
Secondary Outcome  
Outcome  TimePoints 
Complications, hospital stay, and cost effectiveness  Post operative 
 
Target Sample Size   Total Sample Size="80"
Sample Size from India="80" 
Final Enrollment numbers achieved (Total)= "Applicable only for Completed/Terminated trials"
Final Enrollment numbers achieved (India)="Applicable only for Completed/Terminated trials" 
Phase of Trial   N/A 
Date of First Enrollment (India)   04/06/2011 
Date of Study Completion (India) Applicable only for Completed/Terminated trials 
Date of First Enrollment (Global)  Date Missing 
Date of Study Completion (Global) Applicable only for Completed/Terminated trials 
Estimated Duration of Trial   Years="3"
Months="0"
Days="0" 
Recruitment Status of Trial (Global)   Not Applicable 
Recruitment Status of Trial (India)  Open to Recruitment 
Publication Details    
Individual Participant Data (IPD) Sharing Statement

Will individual participant data (IPD) be shared publicly (including data dictionaries)?  

Brief Summary  

Introduction

The primary challenge in the management of common bile duct (CBD) stones in association with gallstones is to select the best strategy with regard to success, morbidity and cost-effectiveness. With the rapid development of endoscopic and laparoscopic technology, endoscopic retrograde cholangiopancreatography (ERCP) combined with LC has become the mainstream treatment for CBD stone and gallstone in most medical centers. With advances in laparoscopic technology, laparoscopic CBD exploration is becoming the procedure of choice for patients with CBD stones in centers with surgeons having adequate laparoscopic experience7. There is insufficient information in the literature on the practice of laparoscopic CBD exploration in cases of endoscopically irretrievable stones. This prospective comparative study has been designed to study the outcomes after primary laparoscopic CBD exploration and laparoscopic CBD exploration following unsuccessful endoscopic stone extraction.

Materials and Methods

This study will be carried out in the Department of Surgical Disciplines and Department of Gastroenterology, All India Institute of Medical Sciences, New Delhi. The study will include 80 patients divided into two groups.

Group I: Patients with gallstones and common bile duct stones without any prior intervention

Group II: Patients with gallstones and common bile duct stones with prior attempts at endoscopic stone extraction

All the patients will undergo a single staged procedure i.e. laparoscopic cholecystectomy with laparoscopic common bile duct exploration and stone clearance (LC + LCBDE).

Success will be defined as removal of CBD stones and gallbladder by the intended approach in both the groups i.e. laparoscopic removal. The details of the patients and operative details will be entered in pre structured proforma. All patients will be followed postoperatively for a minimum of one year or till the time they are stone free. Postoperative course of the patients will be noted

 
Close